{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:51:33Z","timestamp":1789480293141,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH535"],"award-info":[{"award-number":["ZR2023QH535"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01668-0","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T07:37:53Z","timestamp":1753861073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CircNOX4 promotes proliferation and resistance by regulating the hsa-miR-6884-5p\/YWHAG Axis and ERK signaling pathway in cholangiocarcinoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Zhangdi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdi","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangshuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"1668_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther 8:455","journal-title":"Signal Transduct Target Ther"},{"key":"1668_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park J-W, Patel T, Pawlik TM, Gores GJ (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60:1268\u20131289","journal-title":"J Hepatol"},{"key":"1668_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/glia.10185","volume":"42","author":"XQ Chen","year":"2003","unstructured":"Chen XQ, Chen JG, Zhang Y, Hsiao WWL, Yu ACH (2003) 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia 42:315\u2013324","journal-title":"Glia"},{"key":"1668_CR3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2174\/1381612829666230622140926","volume":"29","author":"K Chen","year":"2023","unstructured":"Chen K, Zhang J, Beeraka NM, Li J, Sinelnikov MY, Zhang X, Cao Y, Zakharova DK, Nikolenko VN, Reshetov IV et al (2023) Novel perspectives on Nanotechnological and biomedical implications of monotherapy or combination regimen of lactoferrin. Curr Pharm Des 29:1579\u20131591","journal-title":"Curr Pharm Des"},{"key":"1668_CR5","doi-asserted-by":"crossref","unstructured":"Hammond SM (2015) An overview of MicroRNAs. Adv Drug Deliv Rev 87","DOI":"10.1016\/j.addr.2015.05.001"},{"key":"1668_CR6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"SI Ilyas","year":"2013","unstructured":"Ilyas SI, Gores GJ (2013) Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145:1215\u20131229","journal-title":"Gastroenterology"},{"key":"1668_CR7","doi-asserted-by":"crossref","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15","DOI":"10.1038\/nrclinonc.2017.157"},{"key":"1668_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","volume":"6","author":"AE Kam","year":"2021","unstructured":"Kam AE, Masood A, Shroff RT (2021) Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol 6:956\u2013969","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1668_CR9","doi-asserted-by":"publisher","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","volume":"182","author":"G Kara","year":"2022","unstructured":"Kara G, Calin GA, Ozpolat B (2022) RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev 182:114113","journal-title":"Adv Drug Deliv Rev"},{"key":"1668_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.suc.2018.12.004","volume":"99","author":"AS Khan","year":"2019","unstructured":"Khan AS, Dageforde LA (2019) Cholangiocarcinoma Surg Clin North Am 99:315\u2013335","journal-title":"Cholangiocarcinoma Surg Clin North Am"},{"key":"1668_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675\u2013691","journal-title":"Nat Rev Genet"},{"key":"1668_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J (2022) The emerging roles of circrnas in cancer and oncology. Nat Rev Clin Oncol 19:188\u2013206","journal-title":"Nat Rev Clin Oncol"},{"key":"1668_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M (2020) ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol 21:607\u2013632","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1668_CR14","doi-asserted-by":"crossref","unstructured":"Liao W, Feng Q, Liu H, Du J, Chen X, Zeng Y (2023) Circular RNAs in cholangiocarcinoma. Cancer Lett 553, 215980","DOI":"10.1016\/j.canlet.2022.215980"},{"key":"1668_CR15","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME (2023) Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin 73:198\u2013222","journal-title":"CA Cancer J Clin"},{"key":"1668_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","volume":"19","author":"DK Morrison","year":"2009","unstructured":"Morrison DK (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19:16\u201323","journal-title":"Trends Cell Biol"},{"key":"1668_CR17","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1007\/s00204-020-02782-7","volume":"94","author":"J Ni","year":"2020","unstructured":"Ni J, Wang J, Fu Y, Yan C, Zhu M, Jiang Y, Chen J, Ding Y, Fan X, Li G et al (2020) Functional genetic variants in centrosome-related genes CEP72 and YWHAG confer susceptibility to gastric cancer. Arch Toxicol 94:2861\u20132872","journal-title":"Arch Toxicol"},{"key":"1668_CR18","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1080\/21655979.2022.2033382","volume":"13","author":"Y Pei","year":"2022","unstructured":"Pei Y, Zhang H, Lu K, Tang X, Li J, Zhang E, Zhang J, Huang Y, Yang Z, Lu Z et al (2022) Circular RNA circrna_0067934 promotes glioma development by modulating the MicroRNA miR-7\/ Wnt\/\u03b2-catenin axis. Bioengineered 13:5792\u20135802","journal-title":"Bioengineered"},{"key":"1668_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203\u2013222","journal-title":"Nat Rev Drug Discov"},{"key":"1668_CR20","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorshid K, Fard HRS, S., and, Ghaffari SH (2019) An overview of micrornas: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234:5451\u20135465","journal-title":"J Cell Physiol"},{"key":"1668_CR21","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar AA, Poulikakos PI (2014) Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov 13:928\u2013942","journal-title":"Nat Rev Drug Discov"},{"key":"1668_CR22","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/gutjnl-2023-331715","volume":"73","author":"A Shi","year":"2024","unstructured":"Shi A, Liu Z, Fan Z, Li K, Liu X, Tang Y, Hu J, Li X, Shu L, Zhao L et al (2024) Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut 73:1350\u20131363","journal-title":"Gut"},{"key":"1668_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/HEP.0000000000000437","volume":"79","author":"L Shu","year":"2024","unstructured":"Shu L, Li X, Liu Z, Li K, Shi A, Tang Y, Zhao L, Huang L, Zhang Z, Zhang D et al (2024) Bile Exosomal miR-182\/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Hepatology (Baltimore MD) 79:307\u2013322","journal-title":"Hepatology (Baltimore MD)"},{"key":"1668_CR24","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.ygeno.2019.10.006","volume":"112","author":"Q Su","year":"2020","unstructured":"Su Q, Lv X (2020) Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics 112:1680\u20131685","journal-title":"Genomics"},{"key":"1668_CR25","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1111\/jcmm.15258","volume":"24","author":"J-Y Sun","year":"2020","unstructured":"Sun J-Y, Zhang X-Y, Cao Y-Z, Zhou X, Gu J, Mu X-X (2020) Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma. J Cell Mol Med 24:5438\u20135445","journal-title":"J Cell Mol Med"},{"key":"1668_CR26","first-page":"2735","volume":"15","author":"W Tan","year":"2018","unstructured":"Tan W, Liu B, Qu S, Liang G, Luo W, Gong C (2018) MicroRNAs and cancer: key paradigms in molecular therapy. Oncol Lett 15:2735\u20132742","journal-title":"Oncol Lett"},{"key":"1668_CR27","doi-asserted-by":"publisher","first-page":"108659","DOI":"10.1016\/j.ejso.2024.108659","volume":"50","author":"Y Tang","year":"2024","unstructured":"Tang Y, Xu L, Zhang G, Li K, Shi A, Shu L, Zhao L, Li E, Sun K, Pan G et al (2024) Survival analysis and prognostic nomogram for patients with cholangiocarcinoma after radical resection in Asia. Eur J Surg Oncol 50:108659","journal-title":"Eur J Surg Oncol"},{"key":"1668_CR28","first-page":"e2410591","volume-title":"Advanced science","author":"Y Tang","year":"2025","unstructured":"Tang Y, Yuan F, Cao M, Ren Y, Li Y, Yang G, Zhong Z, Liang H, Xiong Z, He Z et al (2025) CircRNA-mTOR promotes hepatocellular carcinoma progression and lenvatinib resistance through the PSIP1\/c-Myc Axis. Advanced science. Weinheim, Baden-Wurttemberg, Germany, p e2410591"},{"key":"1668_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah R, Yin Q, Snell AH, Wan L (2022) RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol 85:123\u2013154","journal-title":"Semin Cancer Biol"},{"key":"1668_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41419-021-03921-3","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Wang J, He Z, Chen P, Jiang X, Chen Y, Liu X, Jiang J (2021) LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Cell Death Dis 12:648","journal-title":"Cell Death Dis"},{"key":"1668_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-022-01582-0","volume":"21","author":"C Xue","year":"2022","unstructured":"Xue C, Li G, Zheng Q, Gu X, Bao Z, Lu J, Li L (2022) The functional roles of the circrna\/wnt axis in cancer. Mol Cancer 21:108","journal-title":"Mol Cancer"},{"key":"1668_CR33","doi-asserted-by":"publisher","first-page":"e7602","DOI":"10.7717\/peerj.7602","volume":"7","author":"W Yuan","year":"2019","unstructured":"Yuan W, Peng S, Wang J, Wei C, Ye Z, Wang Y, Wang M, Xu H, Jiang S, Sun D et al (2019) Identification and characterization of circrnas as competing endogenous RNAs for miRNA-mRNA in colorectal cancer. PeerJ 7:e7602","journal-title":"PeerJ"},{"key":"1668_CR32","doi-asserted-by":"publisher","first-page":"110999","DOI":"10.1016\/j.ygeno.2025.110999","volume":"117","author":"F Yuan","year":"2025","unstructured":"Yuan F, Tang Y, Liang H, Cao M, Ren Y, Li Y, Yang G, Zhong Z, Xiong Z, He Z et al (2025) CircPIK3C3 inhibits hepatocellular carcinoma progression and lenvatinib resistance by suppressing the Wnt\/\u03b2-catenin pathway via the miR-452-5p\/SOX15 axis. Genomics 117:110999","journal-title":"Genomics"},{"key":"1668_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Z, Yang T, Xiao J (2018) Circular rnas: promising biomarkers for human diseases. 34:267\u2013274","DOI":"10.1016\/j.ebiom.2018.07.036"},{"key":"1668_CR36","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.3892\/mmr.2019.10462","volume":"20","author":"W Zhao","year":"2019","unstructured":"Zhao W, Dong M, Pan J, Wang Y, Zhou J, Ma J, Liu S (2019) Circular rnas: A novel target among non\u2013coding RNAs with potential roles in malignant tumors (Review). Mol Med Rep 20:3463\u20133474","journal-title":"Mol Med Rep"},{"key":"1668_CR35","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/HEP.0000000000000552","volume":"79","author":"L Zhao","year":"2024","unstructured":"Zhao L, Liu J, Li K, Zhang C, Chen T, Liu Z, Tang Y, Hu X, Shi A, Shu L et al (2024) PTPN9 dephosphorylates FGFR2 pY656\/657 through interaction with ACAP1 and ameliorates Pemigatinib effect in cholangiocarcinoma. Hepatology (Baltimore MD) 79:798\u2013812","journal-title":"Hepatology (Baltimore MD)"},{"key":"1668_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"W-Y Zhou","year":"2020","unstructured":"Zhou W-Y, Cai Z-R, Liu J, Wang D-S, Ju H-Q, Xu R-H (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19:172","journal-title":"Mol Cancer"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01668-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:06:59Z","timestamp":1769155619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01668-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01668-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have declared no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"allowing the use of retrospective data at the time of admission was obtained from all patients included in the study, and specific consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"164"}}